V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215814 | 20155703 | 1.75 | 89 | Palliative (P) | 2020-01-20 | 2020-02-04 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101061546 |
| 20215821 | 20155704 | 1.82 | 49.9 | Adjuvant (A) | 2020-08-30 | 2020-09-05 | Cetuximab + FOLFIRI cycle1 | 02 | N | OXALIPLATIN + RALTITREXED | 101280153 |
| 20215826 | 20155705 | 1.62 | 70 | Palliative (P) | null | 2019-08-11 | Trial Unspecified | 01 | N | TRIAL | 101861939 |
| 20215829 | 20155706 | 1.79 | 96 | Adjuvant (A) | 2021-07-27 | 2021-08-08 | Sorafenib | 02 | N | SORAFENIB | 101346484 |
| 20215839 | 20155707 | 1.71 | 73 | null | 2020-02-08 | 2020-02-22 | EOX | 2 | Y | CETUXIMAB + IRINOTECAN + MDG | 101378891 |
| 20215842 | 20155708 | 1.57 | 61 | Palliative (P) | 2017-01-01 | 2017-01-08 | Capecitabine 35days + RT | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101500517 |
| 20215848 | 20155709 | 1.79 | 40.6 | Palliative (P) | 2016-12-13 | 2016-12-13 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101034392 |
| 20215850 | 20155710 | 1.64 | 94.6 | null | 2019-10-24 | 2019-10-24 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101503989 |
| 20215852 | 20155711 | 1.7 | 68.5 | Palliative (P) | 2016-10-10 | 2017-08-15 | EOX | 02 | N | EOX | 101287213 |
| 20215863 | 20155712 | 1.57 | 93.9 | Adjuvant (A) | 2019-05-05 | 2019-05-19 | Sorafenib | 02 | null | SORAFENIB | 101337589 |
| 20215865 | 20155713 | 1.87 | 77.6 | Curative (C) | 2019-06-18 | 2019-07-15 | Trial Unspecified | N | Y | TRIAL | 100564415 |
| 20215869 | 20155714 | 1.6 | 100 | Palliative (P) | 2020-08-26 | 2020-09-10 | EOX | 99 | N | EOX | 101706370 |
| 20215870 | 20155715 | null | 78.3 | Palliative (P) | 2019-03-19 | 2019-04-08 | FLUOROURACIL + IRINOTECAN + Panitumumab | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101701784 |
| 20215871 | 20155716 | 1.79 | 47 | Palliative (P) | 2016-11-11 | 2017-02-24 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100947533 |
| 20215872 | 20155717 | 1.7 | 77.4 | null | 2020-01-20 | 2020-01-21 | EOX | 02 | Y | EOX | 100252732 |
| 20215878 | 20155718 | 1.6 | 43 | Neo-adjuvant (N) | 2020-01-18 | 2020-01-31 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100226979 |
| 20215881 | 20155719 | 1.63 | 72 | Palliative (P) | 2018-03-23 | 2018-04-21 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 101536499 |
| 20215882 | 20155720 | 1.63 | 75.9 | Neo-adjuvant (N) | 2019-10-09 | 2019-12-07 | Sorafenib | 02 | Y | SORAFENIB | 100241007 |
| 20215883 | 20155721 | null | 120.4 | Palliative (P) | 2019-12-21 | 2020-01-11 | EOX | N | N | EOX | 101605965 |
| 20215885 | 20155722 | 1.75 | null | Palliative (P) | 2019-01-10 | 2019-02-07 | EOX | 02 | N | EOX | 100759740 |
| 20215886 | 20155723 | 1.7 | 73 | Palliative (P) | 2018-09-27 | 2018-10-13 | Trial Unspecified | 02 | N | TRIAL | 100401252 |
| 20215888 | 20155724 | 1.85 | 82 | Adjuvant (A) | 2019-03-24 | 2019-04-01 | Capecitabine 5days + RT | 02 | N | CAPECITABINE + RT | 101653582 |
| 20215889 | 20155725 | 1.75 | 73.5 | Curative (C) | 2018-08-01 | 2019-10-23 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100037911 |
| 20215890 | 20155726 | 1.54 | 73.4 | Neo-adjuvant (N) | 2017-09-03 | 2020-07-30 | Sorafenib | 02 | N | SORAFENIB | 100065434 |
| 20215894 | 20155727 | 1.67 | 82.2 | Palliative (P) | 2018-04-13 | 2018-06-17 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101324131 |
| 20215900 | 20155728 | 1.59 | 73 | Palliative (P) | 2019-01-15 | 2019-03-30 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101000078 |
| 20215928 | 20155729 | 1.6 | 100 | null | 2020-06-08 | 2020-07-03 | IRINOTECAN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100052320 |
| 20215934 | 20155730 | null | 76.4 | null | 2017-08-17 | 2017-08-25 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101242766 |
| 20215936 | 20155731 | 1.79 | null | Palliative (P) | 2020-10-20 | 2020-11-06 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101630201 |
| 20215940 | 20155732 | 1.78 | 66 | null | 2017-02-11 | 2017-02-11 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100027577 |
| 20215943 | 20155733 | 1.63 | 81.4 | Palliative (P) | 2018-11-13 | 2018-11-13 | Sorafenib | 02 | null | SORAFENIB | 101049715 |
| 20215950 | 20155734 | 1.64 | 76 | Disease modification (D) | 2020-10-18 | 2020-11-20 | EOX | 02 | Y | EOX | 101564066 |
| 20215961 | 20155735 | 1.83 | 118 | 03 | 2020-01-19 | 2020-02-10 | Panitumumab + Irinotecan + MdG | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101620310 |
| 20215966 | 20155736 | 1.62 | 69.9 | null | 2019-11-16 | 2019-11-18 | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 100208596 |
| 20215973 | 20155737 | 1.79 | 81.6 | Palliative (P) | 2017-09-26 | 2017-10-05 | Trial Unspecified | 02 | N | TRIAL | 101424322 |
| 20215974 | 20155738 | 1.75 | 125 | null | 2018-08-24 | 2018-08-26 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101771027 |
| 20215978 | 20155739 | 1.55 | 75.4 | Adjuvant (A) | 2021-03-06 | 2021-04-05 | Oxaliplatin + Raltitrexed | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100567349 |
| 20215979 | 20155740 | 1.66 | 76.7 | null | 2020-05-16 | 2020-05-29 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100155091 |
| 20215993 | 20155741 | 1.64 | 105 | Palliative (P) | 2019-04-24 | 2019-05-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | OXALIPLATIN + RALTITREXED | 101452238 |
| 20215996 | 20155742 | 1.67 | 90.7 | Adjuvant (A) | 2018-09-28 | 2018-09-28 | GO2 TRIAL | 99 | N | TRIAL | 101737527 |
| 20215997 | 20155743 | 1.9 | 89.5 | Palliative (P) | 2019-08-04 | 2019-09-04 | CETUXIMAB + IRINOTECAN + MDG | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 101042616 |
| 20216001 | 20155744 | 1.78 | 66.4 | Palliative (P) | 2019-06-21 | 2019-06-22 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100690738 |
| 20216004 | 20155745 | 1.55 | 56.3 | Not known (9) | null | 2022-02-09 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100298733 |
| 20216008 | 20155746 | 1.65 | 114.4 | Curative (C) | 2017-05-26 | 2017-08-03 | Capecitabine 35days + RT | 02 | N | EOX | 100058043 |
| 20216009 | 20155747 | 1.7 | 91 | Adjuvant (A) | 2013-10-11 | 2016-08-11 | EOX | 2 | N | EOX | 101693591 |
| 20216014 | 20155748 | 1.9 | 65.8 | null | 2019-06-29 | 2020-04-16 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101344523 |
| 20216015 | 20155749 | 1.54 | 75 | null | 2016-02-28 | 2016-04-09 | Trial Unspecified | Y | null | TRIAL | 100791060 |
| 20216017 | 20155750 | 1.57 | 74 | Disease modification (D) | 2021-09-23 | 2021-09-24 | IRINOTECAN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101490386 |
| 20216024 | 20155751 | 1.75 | 81 | Palliative (P) | 2017-07-29 | 2017-08-06 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101241366 |
| 20216028 | 20155752 | 1.82 | 51 | Palliative (P) | 2017-11-23 | 2018-01-04 | EOX | N | Y | TRIAL | 101088180 |